Inc. As the industry pioneer, Incyte has created the world's largest and most comprehensive collection of genomic information.
Genomics is the study of the structure and function of all the genes that comprise an organism.
The relationship of genomics to health and disease has been Incyte's primary focus since the company's inception in 1991. Incyte has also built the world's largest gene distribution center in St. Louis, which provides access to physical copies of the genes, or clones, represented in Incyte's databases. Incyte Genomics builds on the power of our existing market position and more accurately reflects the role we play in advancing greater and more meaningful understanding of the molecular basis of disease. Incyte has partnerships with 18 of the top 20 pharmaceutical companies, as well as collaborations with premier academic research institutions like Cambridge University, the Human Genome Project Center at the University of Washington, and the Huntsman Cancer Institute. Since the beginning of the year, Incyte has also inked alliances with biotech firms like Vertex Pharmaceuticals, Corixa Corporation, and Biogen.